IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis
J. Clin. Invest. Burkhard Becher, et al. 112:1186
doi:10.1172/JCI19079 [Go to this article.]

Problems with a PDF?